Contezolid

DB12796InvestigationalSmall molecule

MRX-I has been used in trials studying the treatment of Bacterial Infections.

Chemical structure of Contezolid
Formula / weight
C18H15F3N4O4 · 408.337 g/mol (avg)
Code names
MRX-I

Resolves to

Compound
UNIIB669M62ELPCAS1112968-42-9ChEMBLCHEMBL3287379PubChem25184541
Structure
InChIKeySULYVXZZUMRQAX-NSHDSACASA-NSMILESFC1=C(N2CCC(=O)C=C2)C(F)=C(F)C(=C1)N1C[C@H](CNC2=NOC=C2)OC1=O
Targets
P27338MAOBP21397MAOA

What you can answer from here — as of September 20, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
8Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Contezolid, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In